查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1620650

个人化医疗市场：按产品、应用和最终用户划分 - 全球预测 2025-2030

Personalized Medicine Market by Product (Personalized Medical Care, Personalized Medicine Diagnostics, Personalized Medicine Therapeutics), Application (Antiviral, Cardiology, Immunology), End Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年个人化医疗市场价值为5421亿美元，预计到2024年将达到5755亿美元，复合年增长率为6.67%，预计到2030年将达到8520.2亿美元。

个人化医疗 (PM) 是医疗保健领域的一种变革性方法，重点是根据个人的遗传、环境和生活方式因素量身定制治疗方案。其范围涵盖基因组学、药物基因组学和对于制定准确治疗计划至关重要的高级诊断学。随着患者对客製化治疗解决方案的需求不断增加、慢性病盛行率的增加以及体学技术的进步，对个人化医疗的需求也在不断增长。应用领域涵盖从肿瘤学（标靶治疗为癌症患者带来新希望）到心血管疾病和罕见遗传疾病，每种疾病都从这种个人化方法中受益匪浅。最终用途领域包括医院、诊断实验室和研究机构，所有这些机构都利用 PM 来改善治疗结果和业务效率。

主要市场统计
基准年[2023] 5421亿美元
预计年份 [2024] 5755亿美元
预测年份 [2030] 8520.2亿美元
复合年增长率（%） 6.67%

加速市场成长的关键因素包括技术进步、研发投资以及促进精准医疗计画的有利法规结构。然而，也存在一些挑战，例如基因序列测定的高成本、对资料隐私的担忧以及将预防医学融入传统医疗实践的复杂性。新的机会也比比皆是，例如将人工智慧和机器学习整合到处理大型资料集集以发现生物标记物，这可以提高预测准确性和治疗效果。

创新研究领域包括开发具有成本效益的定序技术和研究微生物组对药物基因组学的影响。公司可以透过投资结合PM和远端医疗的数位健康解决方案来竞争，以远端提供全面、个人化的护理。儘管市场格局复杂且分散，但成长潜力强劲。为了利用这些机会，公司应专注于策略伙伴关係、技术整合和以患者为中心的服务交付。市场的本质是动态的，并随着技术进步和监管变化而迅速发展，需要不断创新和适应，以实现业务的持续成长和竞争的加剧。

市场动态：揭示快速发展的个人化医疗市场的关键市场洞察

供需的动态交互作用正在改变个人化医疗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 增加生物技术研究倡议并提高对遗传学的了解
    • 快速采用针对复杂疾病的个人化治疗策略
    • 政府支持措施，以提高对个人化医疗的认识和获取
  • 市场限制因素
    • 实施个人化医疗的复杂性和缺乏熟练人员
  • 市场机会
    • 持续的研发活动以改善个人化医疗
    • 采用虚拟和数位策略进行个人化医疗的可能性
  • 市场问题
    • 可访问性有限和准确性问题

波特五力：驾驭个人化医疗市场的策略工具

波特的五力架构是了解个人化医疗市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解个人化医疗市场的外部影响

外部宏观环境因素在塑造个人化医疗市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解个人化医疗市场的竞争格局

个人化医疗市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：个人化医疗市场供应商的绩效评估

FPNV 定位矩阵是评估个人化医疗市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：规划个人化医疗市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，个人化医疗市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开发：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 加强生物研究力度并提高对遗传学的了解
      • 快速采用针对复杂疾病的个人化治疗策略
      • 政府支持活动以提高对个人化医疗的认识和获取
    • 抑制因素
      • 实施个人化医疗的复杂性和缺乏熟练人员
    • 机会
      • 持续的研发活动以改善个人化医疗
      • 采用虚拟和数位策略进行个人化医疗的可能性
    • 任务
      • 可访问性限制和准确性问题
  • 市场区隔分析
    • 产品：引进个人化营养健康，提升身心健康意识
    • 应用：由于需要精准治疗，个人化医疗在神经学的应用越来越多
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章个人化医疗市场：副产品

  • 介绍
  • 个人化医疗
    • 医疗资讯技术
    • 远端医疗
  • 个性化医疗诊断
    • 直接面向消费者 (DTC) 诊断
    • 深奥化验服务
    • 深奥的实验室测试
    • 基因检测
  • 个人化治疗
    • 基因组医学
    • 医疗设备
    • 製药
  • 个人化营养与健康
    • 补充和替代医学
    • 零售营养品

第七章个人化医疗市场：依应用分类

  • 介绍
  • 抗病毒药
  • 心臟病学
  • 免疫学
  • 神经病学
  • 肿瘤学
  • 心理保健

第八章个人化医疗市场：依最终用户分类

  • 介绍
  • 学术研究机构与实验室
  • 生物与健康资讯公司
  • 合约研究组织
  • 诊断公司和检测机构
  • 医院和临床护理

第九章美洲个人化医疗市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太个人化医疗市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲个人化医疗市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 阿斯特捷利康收购 Fusion Pharmaceuticals 开发个人化癌症药物
    • CurifyLabs 从 Mehta Heino Industries 收购关键 3D 列印 IP，以推进个人化医疗解决方案
    • 策略性收购增强诺华精准医疗能力
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Amgen, Inc.
  • AstraZeneca
  • Bayer Ag
  • BIOGEN INC.
  • Eli Lilly and Company
  • Exact Sciences Corporation
  • Exagen Inc
  • F. Hoffmann-La Roche Ltd
  • GE HealthCare Technologies Inc.
  • Glaxosmithkline Plc.
  • Illumina, Inc.
  • Johnson & Johnson Services, Inc.
  • Laboratory Corporation of America Holdings
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Precision Biologics, Inc.
  • QIAGEN GmbH
  • Takeda Pharmaceutical Company Limited
Product Code: MRR-4D00F1312F65

The Personalized Medicine Market was valued at USD 542.10 billion in 2023, expected to reach USD 575.50 billion in 2024, and is projected to grow at a CAGR of 6.67%, to USD 852.02 billion by 2030.

Personalized medicine (PM) represents a transformative approach in healthcare, focusing on tailoring treatments to individual genetic, environmental, and lifestyle factors. Its scope encompasses genomics, pharmacogenomics, and advanced diagnostics, essential for devising precise treatment plans. The necessity of personalized medicine grows with the rising patient demand for customized therapeutic solutions, increased prevalence of chronic diseases, and advancements in omics technologies. Application areas range from oncology, where targeted therapies offer new hope for cancer patients, to cardiovascular diseases and rare genetic disorders, each benefiting significantly from this personalized approach. End-use segments include hospitals, diagnostic labs, and research institutions, all of which leverage PM to enhance treatment outcomes and operational efficiencies.

KEY MARKET STATISTICS
Base Year [2023] USD 542.10 billion
Estimated Year [2024] USD 575.50 billion
Forecast Year [2030] USD 852.02 billion
CAGR (%) 6.67%

Key factors accelerating market growth include technological advancements, investment in research and development, and favorable regulatory frameworks promoting precision medicine initiatives. However, there are challenges such as high costs of genomic sequencing, data privacy concerns, and the complexity of integrating PM into traditional healthcare practices. Nevertheless, emerging opportunities abound, such as the integration of artificial intelligence and machine learning in processing large datasets for biomarker discovery, which can enhance predictive accuracy and treatment efficacy.

Innovative research areas include the development of cost-effective sequencing technologies and the exploration of microbiome influence on pharmacogenomics. Businesses can gain a competitive edge by investing in digital health solutions that combine PM with telemedicine, offering comprehensive, personalized care remotely. Despite being a complex and fragmented landscape, the personalized medicine market offers robust growth potential. To harness these opportunities, companies should focus on strategic partnerships, technological integration, and patient-centric approaches to service delivery. The nature of the market is dynamic, evolving rapidly with technological advancements and regulatory changes, necessitating continuous innovation and adaptation for sustained business growth and competitiveness.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Personalized Medicine Market

The Personalized Medicine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in biotechnology research initiatives and improved understanding of genetics
    • Surge in the adoption of personalized treatment strategies for targeting complex diseases
    • Supportive government initiatives to raise awareness for and access to personalized medicine
  • Market Restraints
    • Complexities in the implementation of personalized medicine and lack of skilled personnel
  • Market Opportunities
    • Ongoing R&D activities for improvements in personalized medicines
    • Potential for the adoption of virtual and digital strategies for personalized medicine
  • Market Challenges
    • Limited accessibility and issues related to accuracy

Porter's Five Forces: A Strategic Tool for Navigating the Personalized Medicine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Personalized Medicine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Personalized Medicine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Personalized Medicine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Personalized Medicine Market

A detailed market share analysis in the Personalized Medicine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Personalized Medicine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Personalized Medicine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Personalized Medicine Market

A strategic analysis of the Personalized Medicine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Personalized Medicine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amgen, Inc., AstraZeneca, Bayer Ag, BIOGEN INC., Eli Lilly and Company, Exact Sciences Corporation, Exagen Inc, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., Glaxosmithkline Plc., Illumina, Inc., Johnson & Johnson Services, Inc., Laboratory Corporation of America Holdings, Merck & Co., Inc., Novartis International AG, Pfizer Inc., Precision Biologics, Inc., QIAGEN GmbH, and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Personalized Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Personalized Medical Care, Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, and Personalized Nutrition & Wellness. The Personalized Medical Care is further studied across Health Information Technology and Telemedicine. The Personalized Medicine Diagnostics is further studied across Direct-to-consumer (DTC) Diagnostics, Esoteric Lab Services, Esoteric Lab Tests, and Genetic Testing. The Personalized Medicine Therapeutics is further studied across Genomic Medicine, Medical Devices, and Pharmaceutical. The Personalized Nutrition & Wellness is further studied across Complementary & Alternative Medicine and Retail Nutrition.
  • Based on Application, market is studied across Antiviral, Cardiology, Immunology, Neurology, Oncology, and Psychiatry.
  • Based on End Users, market is studied across Academic Research Institutes & Research Laboratories, Bio & Health Informatics Companies, Contract Research Organizations, Diagnostic Companies & Testing Facilities, and Hospitals & Clinical Care.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in biotechnology research initiatives and improved understanding of genetics
      • 5.1.1.2. Surge in the adoption of personalized treatment strategies for targeting complex diseases
      • 5.1.1.3. Supportive government initiatives to raise awareness for and access to personalized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities in the implementation of personalized medicine and lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing R&D activities for improvements in personalized medicines
      • 5.1.3.2. Potential for the adoption of virtual and digital strategies for personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Limited accessibility and issues related to accuracy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing awareness about physical health and mental health owing to the adoption of personalized nutrition & wellness
    • 5.2.2. Application: Increased adoption of personalized medicine in neurology due to the need for precise treatment
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Personalized Medicine Market, by Product

  • 6.1. Introduction
  • 6.2. Personalized Medical Care
    • 6.2.1. Health Information Technology
    • 6.2.2. Telemedicine
  • 6.3. Personalized Medicine Diagnostics
    • 6.3.1. Direct-to-consumer (DTC) Diagnostics
    • 6.3.2. Esoteric Lab Services
    • 6.3.3. Esoteric Lab Tests
    • 6.3.4. Genetic Testing
  • 6.4. Personalized Medicine Therapeutics
    • 6.4.1. Genomic Medicine
    • 6.4.2. Medical Devices
    • 6.4.3. Pharmaceutical
  • 6.5. Personalized Nutrition & Wellness
    • 6.5.1. Complementary & Alternative Medicine
    • 6.5.2. Retail Nutrition

7. Personalized Medicine Market, by Application

  • 7.1. Introduction
  • 7.2. Antiviral
  • 7.3. Cardiology
  • 7.4. Immunology
  • 7.5. Neurology
  • 7.6. Oncology
  • 7.7. Psychiatry

8. Personalized Medicine Market, by End Users

  • 8.1. Introduction
  • 8.2. Academic Research Institutes & Research Laboratories
  • 8.3. Bio & Health Informatics Companies
  • 8.4. Contract Research Organizations
  • 8.5. Diagnostic Companies & Testing Facilities
  • 8.6. Hospitals & Clinical Care

9. Americas Personalized Medicine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Personalized Medicine Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Personalized Medicine Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. AstraZeneca Acquires Fusion Pharmaceuticals for Personalized Cancer Medicine
    • 12.3.2. CurifyLabs Acquires Key 3D Printing IP from Mehta Heino Industries to Advance Personalized Medicine Solutions
    • 12.3.3. Strategic Acquisition Enhances Novartis' Precision Medicine Capabilities
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Amgen, Inc.
  • 3. AstraZeneca
  • 4. Bayer Ag
  • 5. BIOGEN INC.
  • 6. Eli Lilly and Company
  • 7. Exact Sciences Corporation
  • 8. Exagen Inc
  • 9. F. Hoffmann-La Roche Ltd
  • 10. GE HealthCare Technologies Inc.
  • 11. Glaxosmithkline Plc.
  • 12. Illumina, Inc.
  • 13. Johnson & Johnson Services, Inc.
  • 14. Laboratory Corporation of America Holdings
  • 15. Merck & Co., Inc.
  • 16. Novartis International AG
  • 17. Pfizer Inc.
  • 18. Precision Biologics, Inc.
  • 19. QIAGEN GmbH
  • 20. Takeda Pharmaceutical Company Limited

LIST OF FIGURES

  • FIGURE 1. PERSONALIZED MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. PERSONALIZED MEDICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PERSONALIZED MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PERSONALIZED MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PERSONALIZED MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PERSONALIZED MEDICINE MARKET DYNAMICS
  • TABLE 7. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HEALTH INFORMATION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY TELEMEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIRECT-TO-CONSUMER (DTC) DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ESOTERIC LAB SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ESOTERIC LAB TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENOMIC MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COMPLEMENTARY & ALTERNATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY RETAIL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ANTIVIRAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PSYCHIATRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES & RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY BIO & HEALTH INFORMATICS COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTIC COMPANIES & TESTING FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HOSPITALS & CLINICAL CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 245. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 252. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 259. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 260. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 266. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 267. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 295. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 302. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONAL